March 29, 2024 18:18 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi to kickstart BJP's Lok Sabha poll campaign from Meerut | Kangana Ranaut in Mandi: 'Don't think I am a heroine, consider me as your sister and daughter' | Mayawati, Akhilesh Yadav demand high-level probe into Mukhtar Ansari's death | PM Modi has mastered art of manipulating democracy, hurting Constitution: Mallikarjun Kharge | Mafia-turned-politician Mukhtar Ansari dies of cardiac arrest at 63
Covaxin taken off clinical trial mode, no consent forms required Covaxin

Covaxin taken off clinical trial mode, no consent forms required

India Blooms News Service | @indiablooms | 11 Mar 2021, 10:08 pm

New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.

The decision by the Drugs Controller General of India (DCGI) comes a day after a subject expert committee that has been monitoring the development of the drug made a recommendation in this regard.

"...after detailed deliberation the committee recommended for omission of the condition of the use of the vaccine in clinical trial mode. However, the vaccine should be continued to be used under restricted use in emergency situation condition," the DCGI said in a letter to the Hyderabad-based company.

"Further, the ongoing phase 3 clinical trial should be continued as per the approved protocol," it added.

Covaxin has been declared to be an 81 per cent success.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.

The DCGI decision is based on the interim efficacy rate data released by the company.

The regulator has asked Bharat Biotech to keep providing its data from the ongoing phase 3 trials. It has also directed the company to submit a revised summary of the characteristics of the drug. 

Apart from the waiver to consent form, those who take the vaccine will now not be needed to go through seven-day monitoring by medical teams.

"Covaxin is now in regular emergency use authorisation. This has taken the authorisation for Covaxin to another level. Both vaccines (Covaxin and Covishield) now have the same intensity of licensure. Therefore, it is a great day. Covaxin has now been given to more than 19 lakh people and there have been only 311 cases of side-effects. Covaxin has stood the test of time," Dr VK Paul, Head of India's Vaccine administration Committee, said on Thursday.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.